Novo Nordisk A/S (NOVO-B.CO)
Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
As of 11:14AM CEST. Market open.
| Previous close | 808.30 |
| Open | 807.00 |
| Bid | 803.40 x 0 |
| Ask | 803.60 x 0 |
| Day's range | 802.70 - 811.80 |
| 52-week range | 534.70 - 834.50 |
| Volume | |
| Avg. volume | 1,893,649 |
| Market cap | 1.832T |
| Beta (5Y monthly) | 0.32 |
| PE ratio (TTM) | 40.22 |
| EPS (TTM) | 19.98 |
| Earnings date | N/A |
| Forward dividend & yield | 10.40 (1.39%) |
| Ex-dividend date | 25 Mar 2022 |
| 1y target est | 784.25 |
- Zacks
Here's Why You Should Retain Edwards Lifesciences (EW) Now
Investors are optimistic about Edwards Lifesciences' (EW) strong segmental performance and the growing demand for its RESILIA tissue valves.
- Zacks
Reasons Why You Should Invest in ResMed (RMD) Stock Now
Investors are optimistic about ResMed's (RMD) robust mask and device sales and continued product innovations.
- Zacks
Biogen (BIIB) Lecanemab Gets FDA Priority Tag for Alzheimer's
The FDA sets a target date of Jan 6, 2023 for Biogen (BIIB) and partner Eisai's regulatory filing, which seeks accelerated approval for lecanemab to treat Alzheimer's disease (AD).
© 2022 Yahoo. All rights reserved.
